Literature DB >> 8318045

The synthetic retinoid (4-hydroxyphenyl)retinamide decreases collagen expression in vitro and in the tight-skin mouse.

A M Delany1, C E Brinckerhoff.   

Abstract

OBJECTIVE: We documented the effect of the retinoid (4-hydroxyphenyl)retinamide on collagen expression in a tissue culture and in an animal model of scleroderma.
METHODS: We used RNA analysis, chloramphenicol acetyltransferase assays, organ culture, and histologic evaluation.
RESULTS: We showed that (4-hydroxyphenyl)retinamide decreases alpha 1(I) collagen messenger RNA and transcription in cultured cells, and decreases collagen levels in the dermis of tight-skin mice.
CONCLUSION: These results provide a basis for further experiments to address the efficacy of (4-hydroxyphenyl)retinamide in the treatment of scleroderma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318045     DOI: 10.1002/art.1780360716

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  2 in total

1.  A patient with localized scleroderma successfully treated with etretinate.

Authors:  Tomoko Shima; Yuki Yamamoto; Takaharu Ikeda; Fukumi Furukawa
Journal:  Case Rep Dermatol       Date:  2014-09-03

2.  All-Trans Retinoic Acid Induces CD4+CD25+FOXP3+ Regulatory T Cells by Increasing FOXP3 Demethylation in Systemic Sclerosis CD4+ T Cells.

Authors:  Xiaohong Sun; Yangfan Xiao; Zhuotong Zeng; Yaqian Shi; Bingsi Tang; Hai Long; Takuro Kanekura; Jiucun Wang; Haijing Wu; Ming Zhao; Qianjin Lu; Rong Xiao
Journal:  J Immunol Res       Date:  2018-04-30       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.